Emma Palmer

Emma Claire Palmer

Associate Professor of Clinical

Associate Professor

James L Winkle College of Pharmacy
3255 Eden Avenue
P.O. Box 670004
Cincinnati, Ohio 45267-0004
Phone 5135584350
Email Emma.Palmer@uc.edu

Professional Summary

Dr. Palmer graduated from Massachusetts College of Pharmacy (MCPHS) in 2011 with a minor concentration in health psychology. During her education, she participated in multiple college activities including the completion of an undergraduate research fellowship for which she received a Research Scholar Award from MCPHS.

After graduation, Dr. Palmer completed a pharmacy practice residency at Lahey Clinic Medical Center in Burlington, MA. She participated in multiple inpatient and ambulatory services during her residency and completed a teaching certificate program provided by Northeastern University in Boston, MA. She continued on to complete a specialty residency in psychiatry through the Louis Stokes Cleveland Veterans Affairs Medical Center in Cleveland OH where she precepted students from multiple colleges of pharmacy in the area and provided weekly lectures to medical students on rotation from Case Western University School of Medicine in addition to clinical services provided to patients. Following residency, she worked as an assistant, then associate professor for Sullivan University College of Pharmacy and Health Sciences (SU COPHS).

She is currently an associate professor at the James L Winkle College of Pharmacy at University of Cincinnati.

Dr. Palmer currently holds an active license as an RPh in Massachusetts and Kentucky and is a board certified pharmacotherapy specialist and board certified psychiatric pharmacist.


Doctor of Pharmacy: MCPHS University Boston, MA, 2011

Research and Practice Interests

Severe mental illness, substance use disorders, academic assessment

Research Support

Grant: #N/A Investigators:Palmer, Emma 07-01-2020 -06-30-2021 UC's Launch Awards Spring Semester (20SS) Research Launch Awards Role:PI $2,500.00 Active Level:Internal UC


Published Abstracts

Grgurich P, Gray A, Palmer E (2012. ) Evaluation and identification of opportunities for improvement of a daily awakening and spontaneous breathing trial protocol in clinical practice .[Abstract]Critical Care Medicine, 40 (12 ) ,1

Peer Reviewed Publications

Palmer E, Fuller M (2013. ) Obsessive-Compulsive Disorder in Pediatrics and Adolescents: Review of Treatment and Future Directions.Ment Health Clin, , 2 (12 ) ,406 More Information

Palmer EC, Frederick EK (2014. ) Clearing the air: Chronic respiratory illnesses and smoking cessation in the adult psychiatric population.Ment Health Clin, , 4 (3 ) ,153 More Information

Palmer EC, Binns LM, Carey H (2014. ) Levomilnacipran: a new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder.Ann Pharmacother, , 48 (8 ) ,1030 More Information

Riesselman A, Johnson E, Palmer E (2015. ) Lithium and clozapine in suicidality: shedding some light to get out of the dark. .Ment Health Clin, , 5 (5 ) ,237 More Information

Palmer E, Hart S, Feeman PR (2017. ) Development and delivery of a pharmacist training program to increase naloxone access in Kentucky. .J Am Pharm Assoc, , 57 (2S ) ,S118 More Information

Curry B, Palmer E, Mounce C, Smith G, Shah V (2018. ) Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy.Ment Health Clin, , 8 (2 ) ,63 More Information

Palmer EC, Douglass AR, Smith T, Fuentes DG (2018. ) Evaluation of perceptions and knowledge of mental illness in the United States through crowdsourcing.Ment Health Clin, , 8 (5 ) ,227 More Information

Esposito ER, Palmer EC, Douglass AR, et al (2019. ) Intersession remediation to minimize attrition in a three-year pharmacy program. .AJPE, ,

O'Reilly, Frederick E, Palmer E (2019. ) Models for pharmacist-delivered tobacco cessation services: a systematic review.J Am Pharm Assoc, , More Information


Invited Presentations

Palmer EC, Frederick EK (05-20-2019. ) The Write Stuff: Precepting a Medical Writing Residency Elective .Webinar, Other Institution. . Level:State

Palmer EC (01-11-2019. ) Not your “typical” drug review: An update on atypical antipsychotics and considerations for the elderly .PCA Pharmacy Annual Meeting, Louisville KY. Conference. . Level:State

Palmer EC (03-20-2018. ) “Pharmacological management of post-traumatic stress: A pathophysiological approach” .American Psychiatric Nurses Association, Louisville KY. Level:State

Bratberg JP, Freeman PR, Barnes JN, Hill LK, Kwon M, Melton ST, Moody AE, Palmer E (07-17-2017. ) Substance Abuse Education and Assistance SIG: Integrating Opioid Safety and Overdose Prevention Across the Curriculum .American Association of Colleges of Pharmacy, Nashville, TN. Level:National

Palmer EC (04-28-2016. ) Increasing naloxone access in Kentucky: Training pharmacists to initiate naloxone dispensing per-protocol .College of Psychiatric and Neurologic Pharmacists Annual Meeting, Colorado Springs CO. Level:National

Poster Presentations

Caudill C, Stutesman K, Palmer E (04-2019. ) Stigma regarding substance use disorders among student pharmacists: Description and evaluation of impact of an addiction elective on perceptions .CPNP Clinical, Indianapolis, IN. . Level:National

Deckert T, Markwell S, Pham B, Palmer E (05-2017. ) Proper antimicrobial stewardship in a state psychiatric hospital: a retrospective chart review .KSHP Spring Meeting, Louisville, KY. . Level:State

Newby C, Palmer E, Smith B, Shah V (12-2016. ) The Impact of a pharmacist-reviewed medication reconciliation process within a state psychiatric hospital .ASHP Midyear Clinical Meeting, Las Vegas, NV. . Level:National

Palmer E, Hart S, Rippetoe-Freeman P (04-2016. ) Increasing naloxone access in Kentucky: Training pharmacists to initiate naloxone dispensing per-protocol .CPNP Clinical Meeting, Colorado Springs, CO. . Level:National

Curry B, Palmer E, Mounce C, Smith G, Shah V (12-2015. ) Assessing prescribing practices of clozapine before and after the implementation of an updated Risk Evaluation and Mitigation Strategy .ASHP Midyear Clinical Meeting, New Orleans, LA. . Level:National

Burge K, Durham M, Palmer E (12-2015. ) Prevalence of positive drug screen for cannabinoids in patients admitted to a psychiatric facility with psychosis .ASHP Midyear Clinical Meeting, New Orleans, LA. . Level:National

Palmer E, Riesselman A. (04-2015. ) Evaluations of perceptions and knowledge of mental illness in the United States of America through crowdsourcing- Where are we now?” .CPNP Clinical Meeting, Tampa FL. . Level:National

Best K, Mounce C, Palmer E, Strobl B (12-2014. ) Assessing the need for a long acting intramuscular antipsychotic initiation protocol in an acute care psychiatric facility .ASHP Midyear Clinical Meeting, Anaheim, CA. . Level:National

Johnson E, Strobl B, Palmer E, Mounce C (04-2014. ) QT Interval monitoring program: providing clinical services to patients prescribed psychiatric medications that are associated with QT interval prolongation .CNP Clinical Meeting, Phoenix, AZ. . Level:National

Palmer E, Roche J, Fuller M (04-2013. ) Influence of Smoking Status on Time to Discontinuation of Duloxetine in Treatment of Depression”. .CPNP Clinical Meeting , Colorado Springs, CO. . Level:National

Palmer E, Grgurich P, Gray A (12-2011. ) Effects of a pharmacist implemented, nurse-driven sedation titration protocol on mechanically ventilated intensive care unit patients .UHC Pharmacy Council at ASHP, New Orleans, LA. . Level:National

Contact Information

Academic - James L Winkle College of Pharmacy
3255 Eden Avenue
Cincinnati  Ohio, 45267-0004
Phone: 5135584350